Relationship Between Insulin Secretion and Insulin Sensitivity and Its Role in Development of Type 2 Diabetes: Beyond the Disposition Index

We assessed whether the relationship between insulin secretion and sensitivity predicted development of type 2 diabetes in American Indians participating in a longitudinal epidemiologic study. At baseline, when all participants did not have diabetes, 1,566 underwent oral tests and 420 had intravenous measures of glucose regulation, with estimates of insulin secretion and sensitivity. Standardized major axis regression was used to study the relationship between secretion and sensitivity. Distances away from and along the regression line estimated compensatory insulin secretion and secretory demand, respectively. This relationship differed according to glucose tolerance and BMI category. The distance away from the line is similar to the disposition index (DI), de fi ned as the product of estimated secretion and sensitivity, but the regression line may differ from a line with constant DI (i.e., it is not necessarily hyper-bolic). Participants with the same DI but different levels of insulin secretion and sensitivity had different incidence rates of diabetes; lower sensitivity with higher secretory demand was associated with greater diabetes risk. Insulin secretion and insulin sensitivity, analyzed together, predict diabetes better than DI alone. Physiologically, this may re fl ect long-term risk associated with increased allostatic load resulting from the stimulation of insulin hypersecretion by increased glycemia.

[1]  G. Reaven,et al.  Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[2]  F. Alsaraj Pathogenesis of Type 2 Diabetes Mellitus , 2015 .

[3]  M. Pencina,et al.  Interpreting incremental value of markers added to risk prediction models. , 2012, American journal of epidemiology.

[4]  Sara Taskinen,et al.  smatr 3– an R package for estimation and inference about allometric lines , 2012 .

[5]  M. Katakura,et al.  Hyperbolic correlation between insulin sensitivity and insulin secretion fades away in lean subjects with superb glucose regulation. , 2012, Endocrine journal.

[6]  Lloyd E Chambless,et al.  Several methods to assess improvement in risk prediction models: Extension to survival analysis , 2011, Statistics in medicine.

[7]  R. Bergman,et al.  Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes , 2010, Diabetes Care.

[8]  Richard J. Smith Use and misuse of the reduced major axis for line-fitting. , 2009, American journal of physical anthropology.

[9]  R. DeFronzo,et al.  Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels , 2009, Diabetes Care.

[10]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[11]  N. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[12]  M. Westoby,et al.  Bivariate line‐fitting methods for allometry , 2006, Biological reviews of the Cambridge Philosophical Society.

[13]  G. Pacini The hyperbolic equilibrium between insulin sensitivity and secretion. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[14]  S. Kahn,et al.  Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. , 2006, Diabetes care.

[15]  Andrea Mari,et al.  Assessment of insulin secretion in relation to insulin resistance , 2005, Current opinion in clinical nutrition and metabolic care.

[16]  S. Fowler,et al.  Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. , 2005, Diabetes.

[17]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[18]  A. Mari,et al.  Beta cell function and its relation to insulin action in humans: a critical appraisal , 2004, Diabetologia.

[19]  Michael Stumvoll,et al.  Glucose allostasis. , 2003, Diabetes.

[20]  R. Bergman,et al.  Accurate assessment of beta-cell function: the hyperbolic correction. , 2002, Diabetes.

[21]  C. Bogardus,et al.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. , 2000, American journal of epidemiology.

[22]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[23]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[24]  B. Rn,et al.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. , 1989 .

[25]  R. Bergman Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[26]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[27]  R. DeFronzo Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[28]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[29]  S. Lillioja,et al.  In Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians , 1987, Diabetes.

[30]  P. Bennett,et al.  Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. , 1978, American journal of epidemiology.